PPARGC1A and metabolic dysfunction-associated steatotic liver disease: Through its coordination of metabolic pathways in both the liver and the intestine, PGC-1α helps integrate signals from the gut microbiome and dietary inputs, promoting systemic metabolic balance and offering a potential therapeutic target for metabolic diseases such as MASLD, MASH, and insulin resistance.